Literature DB >> 9002130

Successful treatment of progressive outer retinal necrosis syndrome.

R F Spaide1, D F Martin, S A Teich, A Katz, I Toth.   

Abstract

PURPOSE: Progressive outer retinal necrosis is a destructive retinopathy found in patients with acquired immune deficiency syndrome. Treatment of this disorder has been unsuccessful in reported patient series, with the patients experiencing profound bilateral loss of vision.
METHODS: We treated six patients with combination antiviral therapy, usually with intravenous foscarnet and either ganciclovir or acyclovir.
RESULTS: These six patients retained a visual acuity of 20/100 or better in at least one eye for the remainder of their lives (a period > 4 months for each patient). Retinal detachments developed in four patients, for which vitrectomy and silicone oil tamponade were required.
CONCLUSIONS: A combination of intravenous antiviral therapy and aggressive vitrectomy techniques to repair any associated detachments may allow the preservation of useful visual acuity in patients with progressive outer retinal necrosis. This is the first reported series of successful long-term treatment of patients with this disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9002130     DOI: 10.1097/00006982-199616060-00003

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  3 in total

Review 1.  The role of sex in uveitis and ocular inflammation.

Authors:  Ian Y L Yeung; Nicholas A Popp; Chi-Chao Chan
Journal:  Int Ophthalmol Clin       Date:  2015

Review 2.  Antimicrobial guide to posterior segment infections.

Authors:  Tapan P Patel; David N Zacks; Vaidehi S Dedania
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-06       Impact factor: 3.117

3.  Progressive outer retinal necrosis-like retinitis in immunocompetent hosts.

Authors:  Rohan Chawla; Koushik Tripathy; Varun Gogia; Pradeep Venkatesh
Journal:  BMJ Case Rep       Date:  2016-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.